As inflammation is a characteristic condition of obesity, investigating the behavior of inflammation markers with ECW administration, in addition to its action on leptin, is of great importance as it provides data to strengthen the possibility of using this molecule as an alternative in the treatment of obesity. Here, LEP is linked to obesity disorder.